Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Douglas Erbeck is active.

Publication


Featured researches published by Douglas Erbeck.


Toxicologic Pathology | 2005

A study of the potential of the pig as a model for the vaginal irritancy of benzalkonium chloride in comparison to the nonirritant microbicide PHI-443 and the spermicide vanadocene dithiocarbamate

Osmond J. D'Cruz; Douglas Erbeck; Fatih M. Uckun

A porcine model was established to test the mucosal toxicity potential of a thiophene thiourea (PHI-443)-based anti-HIV microbicide and a vanadocene-based spermicide, vanadocene dithiocarbamate (VDDTC) in comparison to benzalkonium chloride (BZK). Nine domestic pigs (Duroc) in nonestrus stage received a single intravaginal application of 2% BZK, 2% PHI-443, or 0.1% VDDTC-containing gel. At various times after gel application, cell differentials and levels of inflammatory cytokines (IL-1β, IL-4, IL-6, IL-8, IL-10, IL-18, IFN-γ, and TNF-α) in cervicovaginal lavage (CVL) fluid were monitored by flow cytometry and ELISA, respectively. Eight pigs were exposed intravaginally to a gel with and without BZK or VDDTC for 4 consecutive days and vaginal tissues were scored histologically for inflammation using a new scoring system. Only CVL fluid from pigs exposed to BZK showed a significant increase of IL-1β, IL-8, and also IL-18 production when compared to the controls, PHI-443 or VDDTC-treated groups. Maximum levels of BZK-induced IL-1β (100-fold), IL-8 (2,500-fold), IL-18 (80-fold), and IFN-γ(10-fold) were found at 24 hours. In the in vivo porcine vaginal irritation model, increased levels of vaginal IL-1β, IL-8, and IL-18 were associated with histological changes consistent with vaginal inflammation. These results demonstrate that key cervicovaginal inflammatory cytokines are useful in vivo biomarkers for predicting the mucosal toxicity potential of vaginal products in the physiologically relevant and sensitive porcine model.


Drug Research | 2011

Toxicity and pharmacokinetics of stampidine in mice and rats

Fatih M. Uckun; Chun-Lin Chen; Elizabeth Lisowski; Greg C. Mitcheltreed; Taracad K. Venkatachalam; Douglas Erbeck; Hao Chen; Barbara Waurzyniak


Toxicology | 2002

Two-year toxicity and carcinogenicity studies in B6C3F1 mice with 5-bromo-6-methoxy-5,6-dihydro-3′-azidothymidine-5′-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent

Osmond J. D'Cruz; Douglas Erbeck; Barbara Waurzyniak; Fatih M. Uckun


Toxicologic Pathology | 2003

Developmental Toxicology Studies of WHI-07, a Novel Nucleoside Analogue-Based Dual-Function Microbicide, Administered Intravaginally to Rabbits

Osmond J. D'Cruz; Douglas Erbeck; Fatih M. Uckun


Drug Research | 2011

Preclinical Toxicity and Pharmacokinetics of the Bruton's Tyrosine Kinase-Targeting Anti-leukemic Drug Candidate, α-Cyano-β-Hydroxy-β-Methyl-N-(2,5-Dibromophenyl) Propenamide (LFM-A13)

Fatih M. Uckun; Heather Tibbies; Taracad K. Venkatachalam; Darin DuMez; Douglas Erbeck


Drug Research | 2011

In vivo pharmacokinetics, metabolism, toxicity, and Anti-HIV activity of N'-[2 -(2-thiophene) ethyl] -N'-[2-(5-bromopyridyl)]thiourea (HI-443), a potent non-nucleoside inhibitor of HIV reverse transcriptase

Fatih M. Uckun; Heather E. Tibbles; Taracad K. Venkatachalam; Douglas Erbeck


Drug Research | 2011

Effect of Targeting Janus Kinase 3 on the Development of Intestinal Tumors in the Adenomatous Polyposis Colimin Mouse Model of Familial Adenomatous Polyposis

Fatih M. Uckun; Douglas Erbeck; Sanjive Qazi; Taracad K. Venkatachalam; HeatherE. Tibbies; Alexei Vassilev


Drug Research | 2011

Improved Oral Bioavailability of Anti-HIV Agent N'-[2-(2-Thiophene)ethyl]-NT-[2-(5-bromopyridyl)]-thiourea (HI-443) in a Novel Lipophilic Formulation

Fatih M. Uckun; Douglas Erbeck; Heather Tibbies; Sanjive Qazi; Taracad K. Venkatachalam


Drug Research | 2011

Developmental safety profile of the anti-HIV agent stampidine in rabbits.

Osmond J. D'Cruz; Douglas Erbeck; Fatih M. Uckun


Drug Research | 2011

Anti-cancer activity profile of 3'-azidothymidine 5'-[p-methoxyphenyl methoxyalaninyl phosphate] (compound 003), a novel nucleoside analog

Fatih M. Uckun; Alexei Vassilev; Ilker Dibirdik; Xing-Ping Liu; Douglas Erbeck; Heather E. Tibbles; Sanjive Qazi; Taracad K. Venkatachalam

Collaboration


Dive into the Douglas Erbeck's collaboration.

Top Co-Authors

Avatar

Fatih M. Uckun

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

Osmond J. D'Cruz

Oklahoma Medical Research Foundation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Osmond J. D’Cruz

University of Oklahoma Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge